ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Arno Therapeutics Inc (CE)

Arno Therapeutics Inc (CE) (ARNI)

0.0001
0.00
(0.00%)
終了 12月28日 6:00AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.0001
買値
0.00
売値
0.00
出来高
-
0.00 日の範囲 0.00
0.000058 52 週間の範囲 0.0003
前日終値
0.0001
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
14,983
財務取引量
-
VWAP
-

ARNI 最新ニュース

Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...

FLEMINGTON, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference

FLEMINGTON, N.J., May 29, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports First Quarter 2014 Financial and Business Update

FLEMINGTON, N.J., May 15, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...

Studies to determine recommended Phase II dose and safety profile of lead compound Will analyze relationship of biomarker to any anti-tumor activity observed FLEMINGTON, N.J., May 14, 2014...

Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual Meeting

FLEMINGTON, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...

FLEMINGTON, N.J., April 7, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational Milestones

FLEMINGTON, N.J., April 1, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014...

FLEMINGTON, N.J., March 26, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman

FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

Arno Therapeutics to Present at 26th Annual ROTH Conference

FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
12000.00010.00010.0001149830.0001CS
26-0.0002-66.66666666670.00030.00030.000174920.0001CS
524.2E-572.41379310345.8E-50.00035.8E-537570.00012027CS
156-0.002-95.23809523810.00210.00211.0E-665097.433E-5CS
260-0.0017-94.44444444440.00180.0421.0E-6640610.0049066CS

ARNI - Frequently Asked Questions (FAQ)

What is the current Arno Therapeutics (CE) share price?
The current share price of Arno Therapeutics (CE) is US$ 0.0001
What is the 1 year trading range for Arno Therapeutics (CE) share price?
Arno Therapeutics (CE) has traded in the range of US$ 0.000058 to US$ 0.0003 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
DTEMFDitem Explorations (CE)
US$ 0.01
(999,900.00%)
1,000
RRMLFRoss River Minerals Inc (CE)
US$ 0.0089
(889,900.00%)
9.95k
FGHFFForte Group Holdings Inc (PK)
US$ 0.3833
(29,384.62%)
432
COUVCorporate Universe Inc (CE)
US$ 0.0002
(19,900.00%)
73.97k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0002
(19,900.00%)
392.07k
CDJMCarnegie Development Inc (CE)
US$ 0.000001
(-100.00%)
2.58k
RAHGFRoan Holdings Group Company Ltd (CE)
US$ 0.000001
(-99.99%)
200
UBMRFUrbanimmersive Inc (CE)
US$ 0.000001
(-99.97%)
1.5k
UNDRUnderSea Recovery Corporation (CE)
US$ 0.000001
(-99.90%)
55k
EICCFE Automotive Inc (CE)
US$ 0.0001
(-99.88%)
5.67k
PHILPHI Group Inc (PK)
US$ 0.0005
(0.00%)
562.38M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.0001
(0.00%)
284.6M
RDARRaadr Inc (PK)
US$ 0.0016
(-5.88%)
170.08M
HMBLHUMBL Inc (PK)
US$ 0.00085
(6.25%)
153.18M
CGACCode Green Apparel Corp (PK)
US$ 0.0004
(-11.11%)
113.22M

最近閲覧した銘柄

Delayed Upgrade Clock